IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹224 Cr | ₹278 Cr | ₹306 Cr | ₹186 Cr | ₹162 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of IPCA LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹224 Cr |
| Mar2025 | ₹278 Cr |
| Mar2024 | ₹306 Cr |
| Mar2023 | ₹186 Cr |
| Mar2022 | ₹162 Cr |
How is Deferred Tax Assets / Liabilities of IPCA LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹224 Cr | -19.32 | |
| Mar2025 | ₹278 Cr | -9.21 | |
| Mar2024 | ₹306 Cr | 65.01 | |
| Mar2023 | ₹186 Cr | 14.31 | |
| Mar2022 | ₹162 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹47,181.9 Cr | -1.4% | -3% | 24.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -1.4% |
-3% |
24.1% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses